In patients with type 1 diabetes (T1D), sodium-glucose cotransporter 2 (SGLT2) inhibitors plus glucagon receptor antagonists (GRAs) may improve glycemic control, reduce insulin use, and mitigate ...

Type 2 diabetes occurs when the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood sugar levels. Medications aim to lower blood glucose, reduce A1C, and ...

Strategic amendment transforms regional partnership into global collaboration; Newsoara gains exclusive worldwide license to develop and ...

DelveInsight's Insulin Resistance Market Insights report includes a comprehensive understanding of current treatment practices, insulin resistance emerging drugs, market share of individual therapies, ...

Top-line results show some promise for a completely new, but still investigational, oral agent, sotagliflozin, in people with type 1 diabetes. Sotagliflozin is a first-in-class, oral dual inhibitor of ...

Medications for type 2 diabetes address different aspects of blood sugar management and are tailored to individual health needs. Navigating type 2 diabetes treatment options can be complex, but ...

Managing type 2 diabetes often means finding the right mix of medications, lifestyle changes, and ongoing support. With many type 2 diabetes medications available today, it can feel overwhelming to ...